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Chairman’s Statement
It was a great honour for me to be elected chair of the Board appointed in May 2002 and to
follow in the able footsteps of my predecessor, Professor Michael Murphy, Dean of Medicine at
University College Cork.
As promised in Making Knowledge Work for Health – A Strategy for Health Research, Minister
Micheál Martin made a number of significant changes to the statutory instrument governing the
Health Research Board that have widened representation on the Board. The seven universities are
now entitled to nominate eight members of the Board and their nominees must be broadly
representative of the disciplines involved in health research. In addition, the Minister for
Enterprise, Trade and Employment and the chief executive officers of the health boards may each
nominate one member. The Minister may also appoint one member active in research in
Northern Ireland, one member from a research charity, one member with expertise in the
pharmaceutical or medical devices industry, and one member of the Department of Health and
Children. The result is a Board that is more representative of the interests and disciplines involved
in health research than formerly, and one that can play a fuller part in the new national research
landscape that has emerged in the past few years.
On its appointment, the Board spent time reviewing its responsibilities for corporate governance
in the light of the importance of the manner in which the Board conducts its business. To assist
us, we were fortunate to have had access to a penultimate draft of the valuable ‘On Board’ guide
subsequently published by the Association of Chief Executives of State Agencies and the Institute
of Public Administration. We are also grateful to David Duffy of Prospectus Consulting who
advised the Board on recent thinking in the private and public sectors on corporate
responsibilities. 
The new Board benefited from the work done by the previous Board in developing a Corporate
Strategy for the Health Research Board for the period 2002–2006. The new Board adopted the
Corporate Strategy to ensure that the HRB plays an effective role in the implementation of the
commitments of Making Knowledge Work for Health and the health strategy Quality and Fairness: 
A Health System for You. The new strategy will also help the HRB play its part in the national task
of building world-class research activity in Ireland to ensure the economic and social
development of the country.
The objectives of the HRB as set out in the Corporate Strategy are: 
1. to encourage the creation and application of  knowledge for health and social gain, the
growth of intellectual property and evidence relevant to health and social gain, and the
emergence of a knowledge-based health system, economy and society;
2. to be the lead national organisation in relation to support for, and co-ordination of, scientific
research for health and social gain, including basic and translational research, health services
research, population health and practice-based research, and to promote the highest ethical
standards in research and good research practice;
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3. to promote the growth of a value-added research and development capability in the health
system, in partnership with other relevant health organisations;
4. to impact on health and social policy and services through high-quality research and
information; 
5. to be the main advocate for the development of research for health and social gain;
6. to make the HRB an employer of choice in its field.
These objectives are based on the following assumptions:
• that the commitments in Making Knowledge Work for Health will be implemented;
• that the funding needed to enhance the role of the HRB will be provided by the Department
of Health and Children;
• that the HRB will retain the confidence of the research community;
• that the demand for research funding from the HRB will grow;
• that peace will prevail on the island and that the international dimension to research will
grow;
• that the HRB will be able to recruit and retain staff with the relevant competencies to develop
its role.
We believe that these objectives are challenging and the assumptions reasonable. The HRB will
undertake in 2005 an organisational audit of its activities to establish the extent to which these
objectives have been achieved.
A highlight of the year was the award of fourteen programme grants following a highly
competitive, peer-review process. These awards, worth 12 million over five years, represented
the largest single investment in research for health ever made by the HRB and resulted from the
exceptional increase in the budget from the Department of Health and Children in 2001. These
awards were in addition to the HRB’s regular project grant and fellowships awards. Three broad
areas of health research were targeted in this call, namely:
• clinical and biomedical research, in particular translational or ‘bench to bedside’ research that
is patient oriented but strongly underpinned by scientific excellence;
• research in health services, epidemiology, public health and primary care that addresses issues
of relevance to health policy and health services in Ireland;
• nursing and midwifery research.
In all three areas, teams were encouraged to take an all-island approach and to include
researchers from Northern Ireland where appropriate. The fourteen successful applicant teams are
now funded to undertake research in their chosen fields to the best standards in the world. The
research undertaken by these teams will increase the profile of Irish research and offer exciting
training opportunities to scientists and healthcare professionals and, over time, will improve the
quality of care to patients and clients of the health services.
One of the signs of the growing maturity of the research environment in Ireland has been the
welcome emergence of new research funding bodies – Science Foundation Ireland, the Research
Council for Science, Technology and Engineering and the Research Council for Humanities and
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Social Science. The emergence of new bodies and enhanced roles for existing bodies such as the
Higher Education Authority highlighted the need to ensure coherence in the operation of these
bodies as they contributed to building world-class research capacity in Ireland. The HRB was
pleased to be a signatory of the ‘Merrion Agreement’ between a number of the research funding
bodies, under which they agreed to work together to ensure coherence and complementarity in
their programmes and operations. The HRB assumed the chair of the standing committee of the
research funding bodies established under the Agreement for its first year. By the end of the year
considerable progress had been made towards achieving greater coherence in programmes of
the participating agencies, making information more easily accessible to the research community,
and standardising some procedures. 
The new priority given to research by government also raised the issue of how best to co-
ordinate research policy and responsibilities at national level. The government responded by
requesting the Irish Council for Science, Technology and Innovation to establish a Commission to
recommend arrangements for the co-ordination of research policy. The CEO of the HRB was
appointed to the Commission by the Minister for Health and Children, and the HRB made a
submission to the Commission in August. The HRB welcomed the opportunity presented by the
Commission to review organisational arrangements and responsibilities for research and to put in
place co-ordinating arrangements that recognised the diversity and complementarity of the
research activities funded by different government departments. The Commission completed its
report in December. The CEO, together with the chairman of the Higher Education Authority, felt
it necessary to include a statement in the final report to highlight the need to protect the
independence of the recommended co-ordinating arrangements for research policy from the
particular interests of any department responsible for co-ordination.
I would like to thank my fellow Board members for their commitment, advice and diligence in
carrying out their responsibilities for governance of the HRB and for promoting the interests of
health research. I would also like to acknowledge the hard work and professionalism of the staff
of the HRB and their contribution to building the profile and capacity of health research in 
this country.
Professor Hugh Brady
Chairman of the Board
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Chief Executive’s Report 
The year 2002 was an extremely busy one for the Health Research Board. The term of office of
the Board appointed in 1997 came to an end in April and a new Board was appointed by
the Minister for Health and Children. Professor Hugh Brady was elected chair at the first meeting
of the Board in June. The Board took up office under a new statutory instrument signed by the
Minister in April that included changes proposed in Making Knowledge Work for Health – 
A Strategy for Health Research and revised governance arrangements. 
The adoption of a Corporate Strategy for 2002-2006 by the outgoing Board and its endorsement
by the new Board was an important step in 2002. The Corporate Strategy was prepared to
ensure that the HRB plays an effective role in the implementation of Making Knowledge Work for
Health and the other aspects of the health strategy, Quality and Fairness, that affect research and
information management for health.
An important step in implementing the Corporate Strategy was the establishment of a new
division in the HRB – Research and Development for Health – to support those commitments of
Making Knowledge Work for Health aimed at building the research and development capacity of
the health system. The new Division made an important contribution to developing activities
under the Ireland–Northern Ireland–National Cancer Institute Cancer Consortium, including the
award, following expert peer review, of funding for cancer clinical trails in four hospitals and the
offer of funding for an all-island co-operative group to co-ordinate cancer clinical trail activity on
the island of Ireland. Access was also negotiated to the Cochrane Library of systematic reviews of
health research from any internet-linked computer on the island of Ireland, representing the first
time that such access was granted anywhere. Fellowships were also offered for the first time by
the HRB to encourage health professionals to undertake systematic reviews of the research on
health issues. 
As part of its role in promoting high ethical standards in research, the HRB published a discussion
document entitled Genetic Research and Human Biological Samples: The Legal and Ethical
Considerations, written by Asim Sheikh of the Department of Forensic Medicine, University
College Dublin.
The National Physical and Sensory Disability Database was launched in March by the Disability
Databases Division and, by the end of the year, almost 15,000 individuals had been registered.
The new database is modelled on the National Intellectual Disability Database, which has proved
so successful in providing comprehensive and accurate information for decision making in relation to
the planning, funding and management of services for people with intellectual disability.
Considerable progress was made in 2002 with the studies in which the Child Health and
Epidemiology Division is collaborating with Trinity College and the US National Institute of Child
Health and Human Development. Recruitment to the studies on folic acid and neural tube defects
has exceeded expectations, with 972 families recruited at the end of the year, of which 491 are
from the Republic of Ireland, 112 are from Northern Ireland and 369 are from England and
Wales. Recruitment to a related study on orofacial clefts has reached 725 families. During the year
the research team published four papers in international peer-reviewed scientific journals. As the
year ended, an application was being made to the US National Institutes of Health to renew the
contract for the studies for another three years.
9
Recruitment targets were met or were exceeded in the case of  the studies on the genetic
epidemiology of schizophrenia and alcoholism in which the Mental Health Research Division is a
partner with Virginia Commonwealth University and which are funded by the US National
Institutes of Health. In a major publication in the American Journal of Genetics, the team identified
a link between the Dysbindin gene, on the long arm of chromosone six, and schizophrenia. The
discovery has been hailed as one of the most significant findings in the molecular study of the
disease. The Division also published the decennial census of the psychiatric inpatient population,
representing a series that goes back to 1961. Information from the National Psychiatric In-Patient
Reporting system was included for the first time in the Public Health Information System
maintained by the Department of Health and Children.
The National Documentation Centre on Drug Use, managed by the Drug Misuse Research
Division, was opened in December. The Documentation Centre includes a state-of-the-art
electronic library of Irish drug-related research that can be accessed online. A research paper on
children attending addiction treatment services in Dublin between 1990 and 1999 has been
accepted for publication in the journal European Addiction Research. The Division published eight
papers on trends in treated drug misuse 1996-2000 and three issues of its successful newsletter,
Drugnet Ireland.
The Irish Council for Science, Technology and Innovation established a Commission to
recommend to government arrangements for the co-ordination of research policy. This was a
welcome opportunity to review the arrangements in other countries for the co-ordination of
research and the place of health research within those arrangements and to recommend the best
framework for Ireland. A government decision on the recommendations of the report is awaited.
The HRB made considerable progress in 2002 in developing its support systems. A Human
Relations and Organisation Development Manager was recruited to assist the HRB become an
employer of choice, as set out in the Corporate Strategy. Much work was done to prepare for the
introduction of a system of performance management and development. The security of the
organisation’s ICT systems was increased and a new website launched. The HRB’s headquarters
was vacated to enable the upgrading of electrical and ICT systems and refurbishment of the
building. New office accommodation was acquired and renovated in Holbrook House.
A disappointment of 2002 was the continued unavailability of a national health information
strategy, as promised by the Department of Health and Children on a number of occasions. As a
key source of information for health, the HRB is keenly aware of the need for a national strategy
to guide the development of information for health and to deal in a consistent manner with data
protection and other issues.
I would like to thank the Chair, Professor Hugh Brady, and the other members of the Board for
their guidance and support during the year and to acknowledge the hard work and commitment
of my colleagues on the staff of the HRB.
Dr Ruth Barrington
Chief Executive
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Research Funding and Policy Division
Research Funding and Policy Division
The Research Funding and Policy Division works to support the first two objectives described in
the HRB Corporate Strategy 2002–2006, namely:
1. To encourage the creation and application of knowledge for health and social gain, the
growth of intellectual property and evidence relevant to health and social gain and the
emergence of a knowledge-based health system, economy and society;
2. To be the lead national organisation in relation to support for, and co-ordination of, scientific
research for health and social gain, including basic and translational research, health services
research, population health and practice-based research, and to promote the highest ethical
standards in research and good research practice.
The Division achieves this by supporting research in third-level institutions and hospitals, and by
participating in national and international fora to promote the strategic development of health
research in Ireland. 
Achievements in 2002
The HRB continued to support high-quality health research through open competition and peer
review. A highlight of 2002 was the successful completion of the HRB’s call for five-year
programme grants. Thirteen programme grants were awarded, worth between 500,000 and
1,000,000 each. The programmes support inter-disciplinary teams working on extensive or
long-term research projects relevant to health in Ireland. The awards made spanned clinical and
biomedical research, in particular ‘translational research’, focusing on the translation of research
findings into improved understanding of disease and its treatment, as well as research in health
services, epidemiology, public health and primary care that addresses issues of relevance to health
policy and health services in Ireland.
The HRB’s project grants schemes provided support for 70 new research projects in Irish
universities and hospitals. These included 60 general project grants, four Ireland–Northern Ireland
co-operation awards, four awards co-funded with other agencies and targeted at health services
research, and two awards made through the inter-disciplinary grants scheme. A special award
was made to a project to explore the possibility of a link between autism and intestinal
dysfunction, with dedicated funding from the Department of Health and Children. The HRB
Summer Student scheme also proved popular, with 46 awards made to undergraduates to carry
out research projects in their summer holidays, while seven travel awards were made jointly with
the British Council. 
The HRB is committed to building capacity in heath research by supporting individual researchers
at different stages in their careers. With this in mind, a total of 25 fellowships were awarded to
professionals to help them to develop their research careers.
Overall, co-operation across the island was much in evidence in the HRB’s research awards. As
well as the four awards made with the R&D Office in Northern Ireland under the
Ireland–Northern Ireland co-operation scheme, cross-border links were a feature of three of the
programme grant awards and two of the fellowships.
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A complete list of grants awarded in 2002 may be found in the Appendix I.
The Health Status and Health Gain Unit in NUI Galway was formally evaluated by an international
review team, which recommended that funding continue for another year. The Unit is gathering
valuable longitudinal information on the health status of three cohorts and aims to report its
findings in 2004.
The Division was also pleased to assist both the Women’s Health Council in its call for a research
programme award in the area of women’s health and the National Implementation Committee in
its call for the Rostered Year Replacement Ratio Project for the BSc in Nursing.  
The Division developed its IT systems further in 2002, a key development being the piloting of a
new, online grant application system (eGrants) for two research committees. The system was
formally evaluated and, in general, was positively received by the research community. In
addition, a new research database was developed to serve as a register of HRB-funded research.
The database records the details of all awards made by the HRB and will assist in evaluating the
outcomes of HRB-funded research.
The Division was involved in a number of events aimed at communicating HRB research to a
wider audience. The Watts Medal was awarded to Shirley Potter, a fifth-year medical student at
NUI Galway, for her project ‘Corticosteroids and fetal vasculature: the effects of hydrocortisone,
dexamethasone and beta methasone on human umbilical artery’. Shirley carried out her project
in the Department of Obstetrics and Gynaecology at NUI Galway under the supervision of
Professor John Morrison. 
The work of the Division was also communicated to the nursing and midwifery professions
through the activities of the joint appointee with the National Council for the Professional
Development of Nursing and Midwifery.
The 2002 Graves Lecture, jointly sponsored by the HRB and the Royal Irish Academy, was given
by Professor Gerald Tomkin from Trinity College Dublin. Following the lecture, Professor Tomkin
was awarded the Graves Medal. 
Receptions were held for new HRB fellows and for the programme grant awards, at which the
Minister for Health and Children was guest of honour. The Division also played an active part in
the JMS Doctor awards.
Throughout 2002, the Division worked on a number of issues relevant to the policy framework in
which the HRB supports research. Guidelines on good research practice were developed and
implemented for all HRB-funded research. The Division completed its work with the Research
Overheads Steering Group established by the HEA and Forfas; the final report will be published in
2003. The Division is committed to working with external organisations on issues of mutual
interest, in particular the other research funding agencies, and played an active part in the
Merrion Group of Funding Agencies. 
Members of the Division represented the HRB as participants in both the Higher Skills Group and
the Steering Group for the Baseline Assessment of the Public Research System in Ireland in the
areas of Biotechnology and ICT. The Division also represented the HRB at the European Medical
Research Council (EMRC), part of the European Science Foundation (ESF). 
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Looking forward
In 2003, the Division will continue to implement the HRB Corporate Strategy by introducing a
number of new research support schemes. A new research fellowship scheme in primary care is
currently being developed with the aim of issuing a call in the second quarter of 2003. A series of
science writing workshops, to be run jointly with the British Council, are planned for 2003, with
the aim of helping researchers in the early stages of their careers to improve their writing skills. 
A targeted call in the area of Hepatitis C and blood utilisation will be completed in 2003.
The evaluation function within the Division will be strengthened further, enabling a more
strategic approach to be taken in identifying funding priorities. An in-depth review of the HRB’s
project grants scheme will be completed, focusing in particular on its role in training. 
Co-ordinating arrangements arising from the ICSTI Commission will be established and
implemented as required by the Department of Health and Children. A plan will be developed to
implement the recommendations of the Research Overheads Report. The Division will continue to
support the HRB’s contribution to the ESF and work with other funding agencies at national and
international level on areas of common interest. 
The Division’s online applications system (eGrants) will be developed further with a view to
moving towards full online applications by 2004.
Four new appointments were made in 2002.  Anne Cody joined the Division as Research Grants
Manager, with responsibility for the Division’s portfolio of grant schemes. Norma O’Donovan
joined as Evaluation Manager, with responsibility for developing the evaluation function within
the Division. With backgrounds in academic research in Ireland and abroad, both brought
additional skills and expertise to the team, which will be crucial in delivering the objectives of the
Corporate Strategy. Sarah Madden joined the team, with responsibility for the development of
the eGrants system. Sarah Condell joined the Division as advisor in nursing research and, working
jointly with the HRB and the National Council for the Professional Development of Nursing and
Midwifery, will lead the implementation of the Strategy for Nursing and Midwifery Research 
in Ireland.
Staff of the Division
Mairead O’Driscoll PhD, Head of Division
Patricia Butler MA
Anne Cody PhD
Sarah Condell BNS MA RGN RM RNT
Patricia Cranley BA
Kay Duggan-Walls BSc HDip
Sarah Madden BA
Fiona McGann BSc
Norma O’Donovan PhD
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Child Health Epidemiology Division
Child Health Epidemiology Division
The Child Health Epidemiology Division of the Health Research Board is involved in
epidemiological research, mainly in the field of pregnancy and child health. The main focus of
the current research programme of the Division is on neural tube defects, orofacial clefts and
other congenital malformations. Key strategic objectives of the Child Health Epidemiology
Division are:
1. To continue the collaborative research programme with the US National Institute of Child
Health and Human Development (NICHD) and Trinity College Dublin (TCD) on the aetiology
and prevention of neural tube defects (NTDs), orofacial clefts and other congenital
malformations.
2. To bid for a further contract from the NICHD to finance the continuation of the above
research programme for a further three-year period. 
3. To investigate the outcome and recurrence risk of spina bifida in Ireland.
Achievements in 2002
Research on congenital malformations
Most of the work of the Child Health Epidemiology Division during 2002 continued to revolve
around the collaborative research programme on congenital malformations involving the Health
Research Board, Trinity College Dublin and the US National Institute of Child Health and Human
Development (NICHD).contract research on neural tube defects (NTDs) and orofacial clefts.  This
research programme has already made significant contributions to understanding the aetiology
and prevention of NTDs and other congenital malformations. The emphasis in this phase of our
research is on recruitment to the studies of families affected by these conditions. 
The research team continued to liaise with branches of the Irish Association for Spina Bifida and
Hydrocephalus (IASBAH), the Northern Ireland Association for Spina Bifida and Hydrocephalus (NI
ASBAH) and ASBAH UK (England and Wales). Recruitment of members from IASBAH and NI
ASBAH took place through special meetings and home visits. Recruitment of members of ASBAH
UK took place through the mailing of self-administered questionnaires and buccal swab samples.
The research team continued to liaise with the public health nurses in the various community
care areas throughout Ireland. Families identified by the public health nurses were recruited
through home visits. To date, 972 families where a member has spina bifida have been recruited:
491 from Ireland, 112 from Northern Ireland and 369 from England and Wales.
Recruitment of families to the orofacial cleft study continued through cleft clinics held at Our
Lady’s Hospital for Sick Children Crumlin, the Children’s Hospital Temple Street, St James’s
Hospital and Sligo General Hospital, and through the Cleft Lip and Palate association of Ireland
(CLAPAI). To date, 725 families where a member has a cleft have been recruited, with 552 from
the hospital clinics and 173 from CLAPAI. Due to the successful recruitment and increased
workload involved with the orofacial cleft study, a Research Assistant was employed in July to
work on the study.
16
Due to the large number of participants being recruited from both studies, a Data Management
Assistant was hired in June to assist with the checking and coding of questionnaires and data
entry onto the study database. During the year the research team published four papers in
international peer-reviewed scientific journals on the Division’s research on congenital
malformations.
Bid for a further contract from the NICHD 
A most important task during 2002 was to prepare a bid for another contract from the NICHD
for a further three-year period to facilitate the continuation and expansion of our collaborative
research programme on congenital malformations. This new research proposal has been finalised
and will be submitted for peer-review assessment to the NICHD in January 2003.
Hip fracture: risk factors and outcome
Hip fracture is a growing public health problem as the proportion of older people in our
population increases. This Division has been collaborating with the Departments of Public Health
Medicine and Epidemiology in University College Dublin and the Departments of Diagnostic
Imagining and Preventive Medicine in St Vincent’s University Hospital Dublin in a case-control
study of hip fracture in older Irish women. The third and final research paper based on this study
was published during the year. This paper reported the findings of a study that compared the
outcome at two years for women who had a hip fracture with that of a control group. The
findings illustrate the devastating effect of hip fracture on a person’s quality of life and underline
the importance of implementing public health strategies to prevent these injuries in older people.
A paper on this study was presented at the Summer Scientific Meeting of the Faculty of Public
Health Medicine of the Royal College of Physicians of Ireland in May.
Looking Forward
Continuing and extending the research on neural tube defects, the Division will co-ordinate
recruitment of subject families through liaison with the relevant associations in Ireland, Northern
Ireland, England and Wales and will continue recruitment of families through the public health
nurses. 
Continuing the research on orofacial clefts, the Division will co-ordinate recruitment of subject
families through liaison with the Cleft Lip and Palate Association of Ireland and through the cleft
clinics at the Children’s Hospital Temple Street, Our Lady’s Hospital Crumlin, St James’s Hospital
and Sligo General Hospital.
An important task for the Division in 2003 will be to submit the bid and prepare any additional
paperwork needed for a further contract from the NICHD for an additional three-year period to
facilitate the continuation of our collaborative research programme on congenital malformations.
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Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O’Leary VB, Parle-
McDermott A, Scott, JM, Swanson DA (2002) A polymorphism, R653Q, in the trifunctional
enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate
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1207–1215. 
Daly S, Mills JL, Molly AM, Conley M, McPartlin J, Lee YJ, Young PB, Kirke PN, Weir DG, Scott JM
(2002) Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age.
Quarterly Journal of Medicine, 95, 733–740. 
Kirke PN, Sutton M, Burke H and Daly L (2002) Outcome of hip fracture in older Irish women: a
2-year follow-up of subjects in a case-control study. Injury, 33, 387–391.
Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM and Daly SE (2002) Maternal and fetal plasma
homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-
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Staff of the Division
Peadar Kirke MB FFPHMI FFPHM MSc DCH DObst, Head of Division
Helen Burke BSocSc
Anne Doyle BSc MA
Ena Lynn RGN RM, HDip
Mary Patricia McKeever PhD
Sharon Murray RGN, RM
Maeve Royston, RGN, RM, BA (Mod)
Marie Sutton MB, BCh, BAO, MPH
Helen Unkovich, BA
Deborah Watson BSc
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Disability Databases Division
Disability Databases Division
The Disability Databases Division of the Health Research Board manages two national service-
planning databases for people with disabilities. Established in 1995, the National Intellectual
Disability Database (NIDD) provides a comprehensive and accurate information base for decision
making in planning, funding, and managing services for people with intellectual disability. The
development of a new database, the National Physical and Sensory Disability Database (NPSDD),
was co-ordinated by the Division and national implementation of this information system
commenced in 2002. The role of the Disability Databases Division is to ensure that relevant and
accurate information is available to enable the Department of Health and Children, the health
boards and the voluntary sector to provide appropriate services designed to meet the changing
needs of people with intellectual, physical or sensory disabilities. The Division assists the HRB in
meeting its corporate objective of impacting on health and social policy and services through
high-quality research and information through its seven key objectives:
1. To establish and build the reputation of the NPSDD nationally in conjunction with our
strategic partners in the Department of Health and Children, the health boards and the
voluntary sector.
2. To establish an information system to provide accurate data on the numbers of people with
autism and their service needs, in conjunction with our strategic partners.
3. To maintain appropriate, comprehensive, high-quality, accessible and timely information on
which to plan and organise services for people with disabilities.
4. To encourage and support regional use of the disability databases.
5. To develop the research, policy, and planning functions of the disability databases. 
6. To promote the disability databases (at national and international levels) through
presentations at national and international scientific conferences and through publications in
national and international scientific journals. 
7. To ensure the disability databases comply with national objectives in relation to health
information, including those of the National Health Information Strategy and the Public
Health Information System, and with health board objectives regarding performance
management.
Achievements in 2002
The Minister for Health and Children formally launched the National Physical and Sensory
Disability Database in March 2002. Throughout the year the Division provided intensive support
to eight health boards as they sought to identify and interview eligible participants. At year-end
almost 15,000 individuals were registered on the database in eight of the ten health boards. The
software in use during initial implementation of the NPSDD was developed, tested and
implemented by the Division, and comprehensive software training was provided to all relevant
health board personnel. The Division recruited software consultants to develop a functional
specification and data model for national, centralised software to support the NPSDD and to
advise on the appropriate telecommunications infrastructure. This was achieved through a
comprehensive consultation process with all stakeholders and was project-managed by the Division.
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As a first step in our longer-term objective to improve regional use of the information contained
in the disability databases, the Division developed and delivered a training programme on the
fundamentals of constructing reports and query generation to 43 users of the National
Intellectual Disability Database in September 2002. Seven health boards submitted their regional
datasets for 2002 to the HRB for analysis in June 2002 and these data have been validated. Data
from one health board are awaited at year-end. The NIDD facilitated the collection of data to
measure two of the four national performance indicators for intellectual disability services.
Exploratory discussions took place between the Division, the Department of Health and Children
and key clinical personnel with a view to identifying the most appropriate method of developing
an information system to identify the numbers of people with autism and their service needs, one
of the key initiatives in the government’s health strategy, Quality and Fairness: A Health System for You.
There was increased use of the disability databases by researchers in 2002, including those
carrying out commissioned research on behalf of other statutory bodies, and the Division is
happy to facilitate the extended use of these important databases. The Division avails of every
opportunity to promote the disability databases at national and international level. Of note in
2002 was the presentation of two papers at the inaugural conference of the International
Association for the Scientific Study of Intellectual Disability (IASSID) Europe in Dublin in June. The
Division continues to provide advice and guidance on the establishment and maintenance of
service-planning databases to colleagues here in Ireland and abroad. During 2002 such assistance
was provided to groups working in Saudi Arabia, Russia, Scotland and Northern Ireland.
The Division’s pages on the revamped HRB website were revised to expand the amount of
information available on our work, to provide extensive detail on the operation of the disability
databases, and to link our work to the delivery of services at health board level. 
Looking forward
The Division’s seven objectives will continue to guide our work in 2003. Priorities include:
• the extension of the NPSDD to all ten health boards;
• the development and implementation of national, centralised software to support the
National Physical and Sensory Disability Database;
• a comprehensive evaluation of the NPSDD involving participants, health boards,
representative groups, and other statutory bodies;
• the identification of an appropriate measure of ability and functioning for adults with physical
and sensory disabilities for inclusion in the NPSDD;
• the publication of annual reports from the NIDD for 2001, 2002 and, pending data
availability, for 2003; and 
• the development of a comprehensive reports module for the NIDD software to further
promote regional use of the database for service-planning purposes.
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Drug Misuse Research Division
The Drug Misuse Research Division (DMRD) is involved in national and international research, and
information gathering and dissemination on drugs and their misuse in Ireland. Through its
activities, the DMRD aims to inform policy and contribute to the academic understanding of drug
misuse. The DMRD is funded by national and EU sources, and by contract research. The Division
maintains the National Drug Treatment Reporting System (NDTRS), a national epidemiological
database on treated drug misuse in Ireland. The Division is also the designated Irish Focal Point of
REITOX (the European Information Network on Drugs and Drug Addiction) which is co-ordinated
by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). As the National
Focal Point, the Division co-operates with other centres across the EU to develop and disseminate
standardised drug-related information. The government has designated the DMRD as the central
point to which all research data and information should be channelled. To facilitate this
informational role, the Division has established the National Documentation Centre on Drug Use.
The Documentation Centre provides access to all relevant and up-to-date information and
research in the field of drug use in Ireland and internationally.
The Drug Misuse Research Division has five core objectives:
• To undertake and facilitate research of the highest scientific standards in the area of drug
misuse;
• To maintain and develop the National Documentation Centre as a national and international
resource on drug misuse;
• To respond in a timely and appropriate manner to the annual workplan of the EMCDDA;
• To continue to expand the coverage of the NDTRS and to increase awareness of the value of
NDTRS data as a basis for research and planning;
• To work closely with key Irish agencies to help address the priority information needs in the
area of drug misuse in Ireland.
Achievements in 2002
Under its contractual obligations with the EMCDDA, the Division prepared a National Report on
the drug situation in Ireland and a progress report on the implementation of the Joint Action on
New Synthetic Drugs. During the year the Division was an active participant in the EMCDDA’s
electronic database on Exchange on Drug Demand Reduction Action (EDDRA). Projects in the
EDDRA database are chosen to represent ‘best practice’ in drug demand reduction activities in
the EU member states. 
In December the National Documentation Centre on Drug Use was opened by Noel Ahern TD,
Minister of State with special responsibility for drugs strategy. The Centre is a unique information
resource providing researchers, policy makers, and other interested parties with access to all
relevant and up-to-date information and research in the field of drug misuse in Ireland and
internationally. One of the unique features of the Centre is an electronic library containing the full
text of all Irish drug-related research, which can be accessed through the Centre’s website
(www.hrb.ie/ndc). 
The Division continued to expand the coverage of the National Drug Treatment Reporting
System (NDTRS). DMRD staff continued to provide training on the concepts and requirements of
the NDTRS to health professionals and service providers involved in the provision of drug
treatment services. 
The Division launched a new publication series (Occasional Papers) to provide researchers, policy
makers and others working in the drugs area with research findings presented in a user-friendly
format. The first eight Occasional Papers focused on trends in treated drug misuse, by health
board area, between 1996 and 2000.
Staff of the Division participated in the expert group on the epidemiology of drug misuse
convened by the Pompidou Group of the Council of Europe. They also contributed information
on the on the extent, patterns and trends in drug misuse in Ireland for the annual report of the
United Nations International Drug Control Programme.
Three issues of Drugnet Ireland, the newsletter of the DMRD, were published in 2002. Its role is to
disseminate information, news and research among interested parties involved in the drugs area
in Ireland. The readership has continually grown during 2002, with over 1,500 copies of each
issue distributed.
A number of staffing changes occurred during 2002. In May Lucy Dillon (Research Officer) left
the Division after more than three years to take up a new post with the Centre for Social Research
in London. In September Aonghus Collins (Information Assistant) was appointed to work in the
new National Documentation Centre on Drug Use. Also in September, Paul Cahill (NDTRS
Analyst) began a three-year career break to work on his doctoral thesis at the University of Ulster.
Earlier in the year Paul was awarded a HRB Health Services Research Fellowship. In December
Mary O’Brien (Senior Researcher and NDTRS Co-ordinator) retired from the HRB after almost 30
years. She will be best remembered for her contribution to the understanding of drug misuse in
Ireland and in Europe.
Looking Forward
In 2003 the Division will update its publication ‘An overview of drug issues in Ireland’. Published
every three years, this resource document provides an overview of issues related to drug use in
Ireland, focusing on information available up to mid-2003. A research paper entitled ‘Children
attending addiction treatment services in Dublin, 1990–1999’ will be published in an academic
journal. Further issues of Drugnet Ireland and the Occasional Papers series are also planned.
Publications
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Mental Health Research Division
Mental Health Research Division
The Mental Health Research Division (MHRD) of the HRB carries out research and information
activities in the field of mental health and mental illness. Staff of the Division are involved in
research projects on the genetics of schizophrenia and alcohol dependence, and service
availability, need and usage in the mental health area. The Division compiles and analyses
national epidemiological information on mental illness in Ireland. Two important databases
relating to mental health, the National Psychiatric In-patient Reporting System (NPIRS) and the
Psychiatric Case Register, are hosted by the Division. The NPIRS collects information on all
admissions to and discharges from psychiatric hospitals and units in Ireland. The Case Register
collects longitudinal information regarding users and usage of inpatient and outpatient
psychiatric services in defined geographical areas in Ireland. Both databases are invaluable sources
of information for planning and research in the mental health area.
Key objectives of the Mental Health Research Division include:
• To further develop the MHRD as a centre of excellence in mental health research.
• To develop the quality and timeliness of the NPIRS as the national epidemiological database
in the mental health area and promote its use as a research, policy and planning tool.
• To develop the quality of the Psychiatric Case Registers based in the MHRD.
• To ensure that the NPIRS and Case Register databases comply with national objectives in
relation to health information, for example, the Public Health Information System, and with
health board objectives regarding performance management – performance indicators.
• To improve communication and dissemination in relation to activities of the MHRD in
accordance with HRB policy and corporate style.
The work of the MHRD is most strongly related to objective 4 of the HRB Corporate Strategy.
Objectives 1 and 6 are also reflected in the work of the Division. Thus, the collection, creation
and application of information, knowledge and research for health and social gain are priority
activities. 
Achievements in 2002
Work continued in 2002 on developing the psychiatric databases based in the MHRD, in
particular their role in relation to evidence-based decision making. 
National Psychiatric In-patient Reporting System (NPIRS): The NPIRS Futures Committee in the
MHRD has been working very successfully on the strategic development and updating of the
NPIRS database. This includes work with the National Mental Health Performance Indicator
Group in the production of performance indicator information at health board level. In addition,
the NPIRS team continues to work to advance computerisation of NPIRS returns, particularly in
the ERHA. The HRB Patient Administration System was redesigned during 2002 and
demonstrated with a view to implementation in a number of facilities. A review of the working of
the NPIRS in each health board is almost completed, following site visits and measures
introduced to increase the timeliness and quality of NPIRS data collection. Work has progressed
on the development of new NPIRS reporting protocols, instruction and training manuals. It is
anticipated that these will be finalised during 2003 and rolled out with MHRD-delivered training
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in each health board area. NPIRS information is being integrated into the Public Health
Information System. This will facilitate a wider dissemination of NPIRS.
A Research and Information Officer was recruited to the Division during 2002. The officer is
working with the NPIRS team in the review, evaluation and promotion of NPIRS and the software
underlying this database. 
Ten regional Bulletins in the form of newsletters based on the Activities report for 2001 and
targeted at each health board area were produced and disseminated, with very positive reaction
and feedback.
Census of Psychiatric Hospital and Units 2001: The decennial census of patients resident in Irish
psychiatric units and hospitals was published in 2002: Irish Hospitals and Units Census 2001. The
census included those resident in hostel facilities.
The Two County Psychiatric Case Registers: During 2002, data input on the Roscommon and
Westmeath Case Registers continued, as did input on the St Loman’s Register. Liaison with
associates working on the registers continued. Re-engineering of the Case Register software
system started in 2002 and this should result in significant efficiencies in the recording of
information. Funding is being sought for a researcher to work on this database.
Mental health research
The MHRD is in the process of carrying out a number of research projects in the mental health
area and funding is being sought for new project start-ups in 2003. In addition, the MHRD is
collaborating with researchers in the universities in the production of academic papers. Provision
and interpretation of data from the NPIRS databases by HRB staff helps inform researchers and
health board personnel carrying out audit and research in the mental health area.
The Day Hospital Study: A study of day hospitals in two health board areas is nearing completion.
The project examines (a) the nature of day hospital and day centre services, (b) the utilisation of
the day hospital and (c) day hospital staff and patient views.
The aims of the study are:
• to identify the extent and appropriateness of current provision;
• to explore the views of mental health specialists;
• to examine the profile of day hospital patients;
• to explore patients’ satisfaction with day hospitals;
• to provide useful indicators as to how the existing provision may be strengthened and revised
as appropriate.
Data were collected by means of questionnaires, psychometric measures and interview
techniques. Fieldwork has been completed and the study will be published in 2003.
The Irish-Affected Sib-Pair Study of Alcohol Dependence: This project aims to identify the specific
loci of the genes that may be involved in susceptibility to alcohol dependence. The Alcohol
Research Project is funded by the US National Institutes of Health, and is carried out in
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collaboration with Virginia Commonwealth University. The fieldwork for the study commenced in
1997 with six field researchers strategically placed throughout the island recruiting and examining
subjects. The study is due to end in January 2003 and, to date, recruitment targets have been
exceeded, with 1,474 participants successfully recruited to the study.
The Irish Schizophrenia Study: This study aims to investigate possible locations for genetic links in
schizophrenia, based on a large body of previous research suggesting a strong genetic component
to the familial transmission of schizophrenia. The study is funded by the US National Institute of
Mental Health. The research is a collaborative endeavour involving the Virginia Commonwealth
University, the Health Research Board and Queen’s University Belfast. Fieldwork has been carried
out in Northern Ireland, the Eastern Regional Health Authority, the Western, Mid-Western and
Southern Health Board areas.  At the end of 2002 there were 680 participants recruited
successfully to the study. This study is due to end in 2003.
Needs Assessment and Service Use – Patients with Chronic Schizophrenia: The clinical and social
needs of a sample of 64 patients with chronic schizophrenia in the St Loman’s catchment area
were assessed using a variety of instruments. This study is being carried out in co-operation with
researchers in six other European countries. Results will be published in 2003.
Mental Illness in Ireland 1750–2001 – The Rise and Fall of Institutional Care in Ireland: Work
continued on this document which is looking at the history of mental illness in Ireland from 1750
to 2001 and, in particular, at the rise of institutionalism and its decline some 250 years later. The
document is due for publication in 2003.
Looking Forward
The five strategic objectives of the MHRD will guide work in 2003. Priorities in relation to NPIRS
include ongoing liaison with and provision of training to personnel in health boards involved in the
return of NPIRS data. Work will continue with the National Mental Health Performance Indicators
to extend computerisation and improve the quality and timeliness of NPIRS returns. The elicitation
of the information needs of stakeholders in the mental health area in the health boards will
commence. This work will feed into discussions on how best to satisfy these information needs and
the implications for the development of the HRB NPIRS and Case Register systems. Quality-control
issues in relation to the Case Registers will be prioritised in early 2003 and the future development
of these registers will be considered in this context. The research studies on the genetics of
schizophrenia and alcohol will close in 2003. The results of the day hospital study will be
published, as will a number of academic papers by Division staff. 
The Division will continue to collaborate with outside researchers, and staff will provide access to
data and interpretations from MHRD databases to researchers in academic and health board
settings. Funding is being sought for specific research projects which would commence during
2003.
The MHRD will continue to work to improve communication and dissemination of its activities in
accordance with HRB policy and Corporate Strategy, aided by the in-house communications
personnel. The release of the 2002 publication Irish Hospitals and Units Census 2001 received
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good publicity in the national and local media. The dissemination in 2002 of NPIRS Bulletins for
each health board individually generated considerable local media coverage. This initiative will be
continued in 2003.
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Research and Development for Health Division
The research strategy document Making Knowledge Work for Health, published in June 2001,
identified the challenge of developing a strong research and development (R&D) culture and
function within the health services and highlighted the contribution that R&D could make to
efficient and high-quality health polices and interventions. In April 2002, the HRB reorganised to
meet the challenge posed by Making Knowledge Work for Health with the establishment of a new
division, Research and Development for Health. The challenge for this Division in the years ahead
is to foster links at a regional and national level between health agencies, the third-level sector,
research charities and the healthcare industry to support a strong R&D function in the health
services, and to do this on an all-island basis where possible. As set out in the HRB Corporate
Strategy, this means being the main advocate for the creation and application of new knowledge
for health and social gain and encouraging the emergence of a knowledge-based health system
and society.
The Division has a number of core objectives:
1. To assist health agencies to develop institutional research strategies to support the growth of
value-added R&D capability in the health system.
2. To promote the translation of research into evidence for decision making (on an all-island and
east-west basis where possible).
3. To improve the standards of research management and commissioning of research by health
agencies.
4. To develop the potential of the Ireland–Northern Ireland–National Cancer Institute Cancer
Consortium to strengthen co-operation on the island of Ireland.
5. To commission research on health issues on behalf of other agencies.
Achievements in 2002
The Cochrane Collaboration aims to help people make well-informed decisions by preparing,
maintaining and promoting the accessibility of systematic reviews of interventions in all areas of
healthcare. The Cochrane Database of Systematic Reviews, the main product of the Cochrane
Collaboration, now contains the full text of 1,600 completed Cochrane Reviews and 1,200
protocols for reviews in progress. In order to promote use of the Cochrane Library of systematic
reviews, free all-Ireland Internet access to the Cochrane Library was negotiated in January 2002,
funded jointly by the HRB and the R&D Office in Belfast. All individuals on the island can now
access the Library by using the web link http://www.update-software.com/clibng/cliblogon.htm.
Promoting the translation of
research into evidence for
decision-making
Three-day training workshops on systematic reviews were held throughout the year in Belfast,
Cork, Dublin and Galway. More than 50 people attended these workshops, which were co-
funded by HRB and the R&D Office, and the feedback was extremely positive. The interest in
attending the workshops was overwhelming and, because the number of people who can attend
these small group sessions is limited, there is already a full waiting list for similar workshops in
2003. The UK Cochrane Centre also held ‘Protocol Writing’ and ‘Introduction to Analysis’
workshops in Dublin and Belfast during the year.
The HRB and the R&D Office co-funded five Cochrane Fellowships to allow fellows from the
island of Ireland to work the equivalent of two days per week for one year on a Cochrane
Systematic Review. These five Reviews are expected to be completed in November 2003.
In June 2002, a working group was convened for the launch of the first All-Ireland Cochrane
Health Libraries Group Prize. A similar prize was conceived in 1997 in the UK to highlight the
contribution that librarians make in promoting the accessibility of reliable research evidence and
its use in clinical practice. The All-Ireland Prize (worth 4,750 and co-funded by the HRB and the
R&D Office) was launched in Tullamore, Co Offaly in October at the annual conference of the
Irish Health Science Librarians Group. The deadline for applications for this prize is August 2003.
Throughout 2002, the HRB took part in meetings of the UK–Ireland Public Health Evidence Group
(UKIPHEG) along with the Institute of Public Health in Ireland, the Public Health Institute of
Scotland, the Health Development Agency (HAD) in England and representatives from the Wales
Health Evidence Bulletins team. This working group was set up to share information and join
forces in efforts to establish and develop the evidence base for public health in each country. The
HRB and the R&D Office in Belfast have agreed to co-fund a researcher to work with the Institute
of Public Health in Ireland to compile an evidence briefing on adolescent para-suicide
management and suicide prevention, in collaboration with Best Health for Children. They will be
aided in search and review methodology by the Cochrane Collaboration and the HAD. This
review represents part of a collaborative programme of work within UKIPHEG, whereby the other
members will also complete a series of evidence briefing documents in a large number of agreed
areas, such as injuries, coronary heart disease, diabetes, mental health.
As part of the drive to encourage use of the evidence base for decision and policy making, the
HRB participated on a committee to organise a conference entitled ‘Making Sense of Sellafield’.
The main aim of the conference, which took place at the Royal Irish Academy in September, was
to provide an opportunity for scientists to present their data to an invited audience of politicians
and policy makers and, where possible, to draw conclusions from their investigations. The
conference provided an opportunity to question key scientists on their findings and to engage
them on the issues of greatest concern in nuclear policy.
Throughout 2002, the HRB made substantial progress with the commissioning of a report
entitled ‘Health and Environmental Effects of Landfilling and Incineration of Waste: A Literature
Review’. This report, which is being commissioned at the request of the Department of
Environment, aims to inform policy makers of (a) the technical aspects of both landfill and
incineration practices and (b) the adverse effects that these practices have on the environment
and human health. The report is scheduled for publication in early 2003.
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Ireland - North Ireland - National Cancer Institute Cancer Consortium
As outlined in the Memorandum of Understanding in 1999, the overarching goal of the Cancer
Consortium is to foster the provision of better prevention, early detection, and treatment of
cancer for all people on the island of Ireland. A key part of this is enabling people with cancer to
gain access to clinical trials. Clinical trials are acknowledged worldwide as the optimal way to
advance cancer care at the bedside, ensure uniformity of practice and even lead to changes in
practice. Because of the relatively small population on the island, it is essential that the two
jurisdictions work with one another and with the United States and other countries in order to
create a pool of participants large enough to generate meaningful findings. The establishment of
the Consortium represented an opportunity to build on initiatives undertaken by the
governments North and South to establish a co-ordinated approach to cancer research on an all-
island basis.
In May 2001, the HRB made awards to six hospitals in Ireland, valued at €4.6 million over three
years, to enhance the capacity of hospitals to conduct high-quality clinical trials. As a sign of its
commitment to this initiative, additional funding was made available by the Department of
Health and Children in 2002 to support the next phase of development. A second call for
funding to hospitals was issued and six applications were received. After evaluation by an
international panel of experts in Dublin in June, awards were made to St James’s Hospital and to
the Mater Misericordiae Hospital in Dublin. Two smaller planning grants were awarded to the
Adelaide and Meath, incorporating the National Children’s Hospital (AMNCH), in Tallaght and
Waterford Regional Hospital. Funding for the second call amounts to approximately €3 million
over three years. Simultaneously, the Northern Ireland Department of Health, Social Services and
Public Safety continued in its effort to restructure cancer services to enhance its clinical research
capabilities. A major cancer unit has been developed at Belfast City Hospital and this will serve as
the co-ordinating hub for activities at the cancer units of the four regional health boards.
In order to reap the dividends of the funding awarded to hospitals across the island, the
Consortium made significant progress in 2002 in establishing a network similar to that of NCI Co-
operative Groups. The Irish Clinical Oncology Research Group (ICORG) in Dublin and the newly
established Clinical Research Support Centre (CRSC) in Belfast submitted a collaborative
application to form an All-Ireland Co-operative Group and this was reviewed by an international
panel of experts in June. A planning grant of 500,000 over two years to each organisation was
recommended by the expert panel and this was linked firmly to reviewing progress against
milestones at nine- and eighteen-month intervals. Further details and the official launch of the
Group are expected in early 2003. The All-Ireland Co-operative Group will be jointly funded by
the HRB and the R&D Office and will be responsible for the generation and conduct of cancer
clinical trials consistent with the priorities on the island and for the provision of organisational,
statistical and scientific support to member hospitals. Group headquarters will be in Dublin, while
data management and statistical functions will be provided by the CRSC in Belfast.
Developing a cadre of well-trained cancer research specialists on the island is a key goal of the
Consortium. During 2002, through its scholar exchange programme, the Consortium facilitated
the exchange of a number of oncologists, nurses, researchers and other cancer personnel
between their home institutions in Ireland and the National Cancer Institute in Bethesda,
Maryland. Funding for travel, accommodation and salary or stipend was provided by the HRB for
participants from the South and on-site training costs were provided by NCI.
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Two clinical oncology nurses from the South completed the three-month clinical trials training
programme in April 2002. The nurses rotated between the NCI Clinical Centre and the National
Naval Medical Centre in Bethesda. Sarah Condell took up a part-time position with the HRB in
June 2002 to advise and co-ordinate HRB nursing and midwifery research schemes and to work
with this Division on Cancer Consortium nursing initiatives
The first Consortium epidemiology fellow from the South, Dr Paul Walsh, concluded his first year
of post-doctoral study in cancer epidemiology in NCI and returned to the National Cancer
Registry in Cork for the remaining two years of the fellowship. Dr Walsh is developing a project
on breast cancer survival with the Registry as part of the overarching goal of translating the
fellows’ experiences into cancer research projects on the island. A second call for epidemiology
fellows was issued in October 2002 and it is anticipated that the HRB will fund another fellow to
travel to NCI in 2003.
The HRB funded 15 individuals to attend NCI’s Summer Curriculum in Cancer Prevention during
July and August. Some attended a four-week segment entitled ‘The Principles and Practices of
Cancer Prevention and Control’, some attended a one-week segment entitled ‘Molecular
Prevention’, and some individuals attended both. The Principles and Practices course covers the
resources, data, methods and theories related to cancer prevention and control. The Molecular
Prevention course provides participants with information on molecular biology and the genetics
of cancer and an overview of the laboratory approaches in epidemiology, bio-nutrition, chemo-
prevention, biomarkers and translational research. A reunion was held for the 16 participants
from 2001 and the returned 2002 participants to coincide with the Cancer Care Conference in
Belfast in October.
The first meeting of the Prevention Working Group was held in Dublin in May 2002. Members
discussed prevention activities in their respective jurisdictions and began to formulate initiatives
that could be undertaken by the Consortium, such as the hosting of workshops addressing those
cancers that utilise the greatest amount of resources or that have the highest rates of morbidity
or mortality on the island.
A highlight for all involved in the Consortium in Ireland was the visit in November by Dr Elias
Zerhouni, Director of the National Institutes of Health (NIH), and Dr Andy Van Eschenbach,
Director of the National Cancer Institute, to launch the TeleSynergyTM suite at St Lukes Hospital.
The visit provided an opportunity to raise the profile of the work of the Cancer Consortium and
has opened up other opportunities for co-operation with the NIH on an all-island basis.
Further details on current and planned Consortium activities can be found on the Cancer
Consortium website at www.allirelandnci.org
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Looking forward
The Division will continue to advance the strategic vision of the HRB in implementing the
recommendations of Making Knowledge Work for Health in relation to R&D for Health. A series of
workshops and seminars to assist health agencies to develop research strategies will begin in
2003 to support the growth of value-added R&D capability in the health system. Work will also
begin on preparing and issuing guidance and advice to improve the standards of research
management and the commissioning of research by health agencies. An additional senior
member of staff will be engaged to work on these initiatives.
Staff of the Division
Teresa Maguire PhD, Head of Division
Bronagh O’ Connor
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Finance and Administration Division
The role of the Corporate Services Division is to equip the HRB with the necessary corporate
governance practices, resources, skills, competencies and internal support structures and systems
to achieve its corporate objectives.
The Divisional objectives are:
• To support the effective working of the Board and its committees, and facilitate the Board’s
programme of promoting continued good corporate governance.
• To develop and implement systems, policies, and procedures that ensure the most effective
and efficient use of the HRB’s financial resources to enable it to achieve its corporate
objectives.
• To provide the Information and Communications Technology (ICT) capability required to
facilitate effective and flexible work practices and the efficient delivery of services to the HRB’s
clients.
• To facilitate the enhanced performance of the organisation by the provision of adequate
office accommodation, reception cover, facilities management and other support services.
Achievements in 2002
Finance
The total income of the HRB for 2002 was €22.8 million (up from €15.3 million in the previous
year), an increase of 49 per cent. Total income for 2002 was made up of revenue income of
€20.9 million and capital income of €1.9 million. Funding received from the Department of
Health and Children accounted for 88 per cent of total income.
Expenditure by the Research Funding and Policy Division on research grants and fellowships
increased by €3.4 million to €14.2 million. The Research and Development for Health Division
was established during the year and its expenditure of €2.6 million was focused on awarding
funding under the Ireland–Northern Ireland–National Cancer Institute schemes.
US-sponsored intramural research activities in the Child Health Epidemiology Division and the
Mental Health Research Division, and EU-sponsored research in the Drug Misuse Research
Division continued to be the main categories of other research expenditure, which increased by
35 per cent to €2.6 million in 2002.
The result for the year was a surplus of €16,749.
Martina Sheridan, a qualified Chartered Accountant, was recruited to the post of Management
Accountant in May, and the first in a series of audits of research institutions was successfully
completed.
Buildings, facilities and other services
Eyre Massy, a qualified engineer, was recruited to the post of Facilities Manager in January; his
remit also covers the areas of ICT and health and safety.
In the first quarter of the year new accommodation was identified in Holbrook House that met
the office space requirements of the HRB, had disabled access and suitable facilities for the
National Documentation Centre on Drug Misuse. The terms of the lease were successfully
negotiated, optimal use of the new office space agreed, and staff moved to their new locations
with minimal business disruption. The health, safety, and welfare of all staff were treated as a
priority at all times during the move.
Tenders for the refurbishment of the Baggot Street offices were received and the contract was
successfully negotiated and work commenced. A project team was established to ensure that the
financial and other obligations of the contract were adhered to.
HRB office opening hours for public access were increased by two hours and fifteen minutes each
day. Carole Marry and Bronagh O’Connor were appointed to the posts of
Receptionist/Administrators.
Sadly, in February 2002 we learnt of the death of Leo Johnson, the HRB’s long-serving
Porter/Services Officer. This vacancy was filled in April by the appointment of Francis Pedreschi. 
Bronagh O’Connor left the Corporate Services Division in December 2002 to join the Research
and Development for Health Division. 
Information and communications technology
In conjunction with the opening of the Holles Street office and the temporary vacating of the
Baggot Street office, the ICT capacity of the HRB was reviewed and enhanced. Internet access
was upgraded to a 2MB leased line with connection directly to HEAnet as well as a 2MB link
between the two HRB offices.
Following a detailed review of requirements, PC operating systems in use in the HRB were
upgraded and e-mail services, on which the HRB is very reliant, were extensively upgraded and
modernised.
Access for teleworkers and other remote users was enabled and facilitated by upgrading the
security and access software and hardware.
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Looking Forward
In 2003 the Corporate Services Division will facilitate the establishment of an internal audit
function, prepare detailed policies and procedures for the working of the HRB’s internal Research
Ethics Committee, develop corporate record-management policies and ensure that the HRB can
meet the requirements of the Freedom of Information Act in advance of its implementation in the
HRB.
The refurbishment of the Baggot Street premises will be completed on time and within the
agreed budget.
Staff of the Division
Carol Cronin BComm FCA, Secretary to the Board, Head of Division
Ashling Dwyer
David Flood
Carole Marry
Eyre Massey BSc(Eng) DipEng MIEI
Bronagh O’Connor
Francis Pedreschi
Yvonne Russell
Martina Sheridan ACA 
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Accounts
Health Research Board
Revenue Income and Expenditure Account
for the year ended 31 December 2002
2002 2001
€ €
Income
Department of Health and Children Revenue Grant 13,008,000 10,714,050
Other Research Funding 2,625,765 1,946,270
Projects Undertaken for the Department of
Health and Children 5,240,893 2,179,260
Interest Receivable 75,745 725
20,950,403 14,869,594
Expenditure
Research Grants and Fellowships 12,942,743 10,383,035
Child Health Epidemiology Division 1,095,539 984,300
Drug Misuse Research Division 639,973 545,114
Mental Health Research Division 1,148,690 866,220
Disability Databases Division 222,413 164,608
Research and Development for Health Division 2,622,762 -
Administration Costs and General Overheads 2,134,934 1,700,504
Pensions Paid to Retired Members of Staff 47,811 62,180
Other Activities 78,788 188,958
20,933,654 14,894,919
Surplus/(Deficit) for the Year 16,749 (25,325)
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Health Research Board
Capital Income and Expenditure Account
for the year ended 31 December 2002
2002 2001
€ €
Income
Department of Health and Children Capital Grant 1,882,073 444,485
Amortisation of Capital Fund Account 132,734 101,293
2,014,807 545,778
Expenditure
Equipment Grants Paid to Third Parties 1,251,740 365,406
Contribution to Fixed Assets 279,834 79,079
Contribution to Premises Upgrading 350,499 -
Depreciation 132,734 101,293
2,014,807 545,778
Surplus/(Deficit) for the Year - -
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Health Research Board
Balance Sheet
for the year ended 31 December 2002
2002 2001
€ €
Fixed Assets
Tangible Assets 545,803 398,703
Current Assets
Debtors 1,917,133 935,843
Investments 641 445,960
Cash at Bank and on Hand 2,610,245 2,623,805
4,528,019 4,005,608
Current Liabilities
Amounts falling due within one year:
Bank and Other Advances 527,196 36,278
Creditors and Deferred Income 3,930,475 3,915,731
4,457,671 3,952,009
Net Current Assets 70,348 53,599
Net Assets 616,151 452,302
Reserves
Accumulated Surplus on Income and
Expenditure Account 70,348 53,599
Capital Fund 545,803 398,703
616,151 452,302
Appendices I & II
Appendix I
HRB Grants Awarded in 2002
Fellowships – Clinical Research Training
Grant Holder Project Title Award
Dr Zainab Abood An investigation of the genetic relationship €126,470
Trinity Centre for Health Science between depression and migraine
St James’s Hospital
Dr Susan Connolly Identification of molecular drivers and novel €124,670
Department of Medicine therapeutic targets in diabetic atherosclerosis
and Therapeutics through complementary analysis of differential 
UCD/Mater gene expression in vascular smooth muscle cells
Misericordiae Hospital
Dr Vincent Dolan Analysis of the expression and function of €136,923
Department of Pharmacology Gremlin in the developing vertebrate kidney
University College Dublin
Dr Stephen Finn Genome wide investigation of Thyroid Neoplasia €123,454
Department of Histopathology
AMNCH
Dr Fidelma Fitzpatrick Will a greater understanding of the factors that €122,987
Department of Microbiology influence adherence to biomaterials and biofilm 
Beaumont Hospital formation by coagulase-negative staphylococci 
lead to better therapeutic and preventive 
measures in neurosurgical infections?
Dr Thomas Flannery Cathepsin S expression in astrocytomas: clinical €61,081
Department of Oncology relevance and role in invasion
QUB/Belfast City Hospital
Dr Trevor Markham Angiogenic growth factors in psoriasis and the €129,638
Dermatology Department effect of anti-TNFa blockade
St Vincent’s University Hospital
Dr Conor O’Brien Cytokine gene polymorphisms and their €89,510
Education and Research Centre association with the outcome of Hepatitis C 
St Vincent’s University Hospital viral infection
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Grant Holder Project Title Award
Dr Donal O’Croinin Investigation of the effects of Hypercapnic €123,454
Department of Physiology Acidosis on acute lung injury induced by 
University College Dublin bacterial infection
Dr Sunita Sukumaran Is Magnetic Resonance Spectroscopy a useful €120,698
Neurology Department marker of dynamic hippocampal changes?  
Beaumont Hospital Assessment of correlates with memory training
in patients who have undergone hippocampectomy 
for intractable temporal lobe epilepsy
Fellowships – Health Services Research
Grant Holder Project Title Award
Mr Paul Cahill A multivariate analysis of the influences and €113,655
Psychology Department profiles of treated drug misuse in Ireland
University of Ulster
Ms Catherine Dineen Assessing the effectiveness of a novel cognitive €44,896
Neuropsychology Department behavior therapy treatment for patients with 
Beaumont Hospital non-epileptic seizures (NES) compared with 
standard psychiatry treatment
Ms Jean Long ‘Unknown’ socio-economic status in national €136,611
Department of Community databases: a socially excluded underclass?
Health and General Practice
AMNCH
Dr Anne MacFarlane Health service delivery in multi-cultural Ireland: €147,521
Department of General Practice perceptions of refugees, asylum seekers and 
NUI Galway primary healthcare providers
Ms Rosemary O’Halpin The effects of cochlear implantation on speech €147,521
Cochlear Implant Programme perception and production skills in children in 
Beaumont Hospital Ireland
Fellowships – Nursing and Midwifery Research
Grant Holder Project Title Award
Ms Claire Coleman An exploration of the acceptability and €92,193
Guide Clinic effectiveness of contact tracing in the context 
St James’s Hospital of an outbreak of syphilis
Ms Gabrielle O’Kelly The impact of nursing experiences on nurses’ €140,511
unconscious mental processes
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Fellowships – Post-Doctoral
Grant Holder Project Title Award
Dr Miriam Brady Role of regulatory T-cells in parasite €163,021
Department of Biochemistry immunosuppression
Trinity College Dublin 
Dr Lorraine Brennan Assessment of cell metabolism and function €162,921
Department of Biochemistry using Nuclear Magnetic Resonance
University College Dublin
Dr Katrina Comerford Hypoxia-elicited P-glycoprotein expression: €163,021
Department of Medicine and potential role in chemotherapeutic resistance
Therapeutics
Mater Misericordiae Hospital
Dr Andrew Harkin A study of the mechanisms by which caffeine €170,021
Department of Pharmacology increases the acute toxicity of methylene-
NUI Galway dioxymethamphetamine (MDMA, ‘Ecstasy’)
Dr Jean-Marc Hyvelin The role of Rho/Rho-kinase in the pulmonary €169,441
Department of Physiology vascular remodelling in chronically hypoxic lungs
University College Dublin
Dr Aileen Lynch What cellular events are responsible for the €163,021
Department of Physiology age-related deterioration in synaptic function in 
Trinity College Dublin the rat hippocampus?
Dr James McRedmond Transcriptome and proteome analysis of platelet €166,546
Department of Clinical phosphoproteins
Pharmacology 
Royal College of Surgeons 
in Ireland
Dr Sarah O’Neill An investigation of the mechanisms of integrin €156,953
Department of Clinical activation
Pharmacology 
Royal College of Surgeons 
in Ireland
Programme Grants
Grant Holder Project Title Award
Professor Hugh Brady Functional and computational genomics approach €1,088,488
Department of Medicine to the identification of novel therapeutic targets 
and Therapeutics in diabetic nephropathy
UCD/Mater 
Misericordiae Hospital
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Grant Holder Project Title Award
Professor Desmond Fitzgerald Programme on cell regulation by cyclooxygenases: €1,100,000
Royal College of Surgeons novel therapeutic targets in cancer
in Ireland inflammation
Professor Timothy Foster The molecular basis of the interaction of €1,047,915
Microbiology Department Staphloccocci with platelets and the 
Trinity College Dublin pathogenesis of invasive and device-related 
infections
Dr Catherine Godson Mechanisms of action and therapeutic potential €600,000
Department of Medicine and of lipoxins in renal disease
Therapeutics 
University College Dublin
Professor Peter Humphries Exploration of therapeutic interventions at the €1,088,499
The Ocular Genetics Unit genetic level in degenerative diseases of the 
Trinity College Dublin retina
Professor Dermot Kelleher Toll-like receptors in human disease €1,087,809
Department of Clinical 
Medicine/ 
Molecular Medicine Centre
St James’s Hospital
Professor Dermot Kenny The platelet as a potential therapeutic paradigm €1,114,000
Royal College of Surgeons in 
Ireland
Professor Noel Lowndes The DNA damage checkpoint and cancer €1,133,006
Department of Biochemistry
NUI Galway
Professor Hannah McGee Maximising quality at the interface between €821,959
Department of Psychology individuals and the healthcare system
Royal College of Surgeons in 
Ireland
Professor Andrew Murphy Secondary prevention of heart disease in €1,075,750
Department of General Practice general practice: a randomised controlled trial 
NUI Galway with qualitative, economic and policy analyses 
of an intervention to produce improved and 
sustained outcomes
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Grant Holder Project Title Award
Professor Brian Nolan The provision and use of health services: €632,501
Economic and Social Research health inequalities and health and social gain
Institute
Professor Denis O’Mullane The benefits and risks of fluoride on the island €570,553
Oral Health Research Centre of Ireland
University College Cork
Professor Anne Scott Nursing decision making: an integrated €999,994
School of Nursing programme of research to maximise the 
Dublin City University effectiveness of clinical nursing resources
Professor Fergus Shanahan Host-bacterial interactions within the gut in €567,000
Department of Medicine health and disease
Cork University Hospital
Research Project Grants – Co-Funded in Health Services Research
Grant Holder Project Title Award
Professor PJ Kearney Does the distance from paediatric oncology €19,675
Department of Paediatrics centres affect the quality of life of children on 
Cork University Hospital cancer chemotherapy?
Dr Regina McQuillan The relationship between the traveller community €19,289
St Francis Hospice and specialist palliative care services in the 
Eastern Regional Health Authority
Mrs Victoria Ononeze A qualitative study of the individual experience €20,000
Department of General Practice of coronary heart disease in the wider context of 
NUI Galway social, cultural and environmental factors
Dr Jane Walsh An evaluation of an intervention to improve €13,873
Department of Psychology attendance rates for cervical screening: the 
NUI Galway impact of biopsychosocial factors on the 
formation of implementation intentions
Research Project Grants – General
Grant Holder Project Title Award
Professor Gregory Julian Atkins Biosafety of the Semliki Forest virus vector: €97,724
Department of Microbiology abrogation of virus-induced demyelination
Trinity College Dublin
52
Grant Holder Project Title Award
Dr Michael Barry The cost effectiveness of three antiretroviral drug €145,351
Department of Clinical regimens for the prevention of mother-to-child
Pharmacology transmission of HIV disease
and Therapeutics
Trinity College Dublin
Dr Kathleen Bennett Influence of deprivation and geographical region €128,250
National Medicines on prescribing patterns
Information Centre  
St James’s Hospital
Professor Hugh Brady Molecular mechanisms of tubulointerstitial fibrosis €159,018
Department of Medicine and in diabetic nephropathy
Therapeutics 
Mater Misericordiae Hospital
Dr David Brayden Myosin light chain kinase inhibitors as potential €126,470
Department of Small Animal therapeutics for inflammatory bowel disease
Clinical Studies 
University College Dublin
Dr Geraldine Butler Genomic analysis of the transcriptional response €142,200
Department of Biochemistry of human macrophage cells to infection with the 
University College Dublin pathogenic yeast  Candida albicans
Dr John Calvin Coffey On the TRAIL to periperative tumour growth: €69,600
Department of Academic Surgery an evaluation of TRAIL mediated apoptosis 
Cork University Hospital following surgery
Dr Michael P Carty Analysis of polymorphisms and mutations in the €144,464
Department of Biochemistry human RAD30 cancer susceptibility gene
NUI Galway
Professor David C Coleman Triclosan-based antagonism of the activity of €152,274
Department of Oral Surgery, azole antifungal drugs against oral Candida 
Oral Medicine and Oral species
Pathology
Trinity College Dublin
Dr Sean Commins Neurophysiology and neuroanatomy of €139,200
Department of Psychology hippocampal-cortical interaction: the role of 
NUI Maynooth the subiculum and entorhinal cortex
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Grant Holder Project Title Award
Professor Kenneth A Dawson Determination of factors controlling €140,500
Department of Chemistry biocompatability
University College Dublin
Professor Kevin Devine Investigation of the essential two-component €150,147
Department of Genetics system YycFg in Staphylococcus aureus, to 
Trinity College Dublin establish its potential as a novel therapeutic target
Professor Timothy G Dinan Overactivation of hypothalamic-pituitary-adrenal €154,057
Department of Pharmacology axis in melancholic depression: studies on the role  
and Therapeutics of Vasopressin
Cork University Hospital
Dr MJ Duffy Role of ADAMs in breast cancer €107,600
Department of Nuclear Medicine
St Vincent’s University Hospital
Dr Gwyneth Jane Farrar Exploration of ribozyme-based suppression of €106,500
Department of Genetics thyrotropin-releasing hormone-degrading 
Trinity College Dublin ectoenzyme (TRH-DE) gene expression as a 
novel therapeutic approach for CNS injury
Professor Desmond Fitzgerald Cyclooxygenases in hypoxia-induced pulmonary €157,178
Department of Pharmacology hypertension
Royal College of Surgeons in 
Ireland
Professor Timothy Foster Adherence of Staphylococcus aureus to elastin is €104,817
Department of Microbiology promoted by the fibronectin binding proteins
Trinity College Dublin
Dr Louise Gallagher Using a deletion within the autism-linked region €164,633
Department of Genetics on chromosome 2 as a tool to map the gene(s)
Trinity College Dublin
Dr Clair M Gardiner Investigation of the functional polymorphism of €170,850
Department of Biochemistry KIR 3DL1 receptor expressed by NK cells
Trinity College Dublin
Professor Michael Gill A prospective study of the clinical genetics of €140,049
Department of Psychiatry methylphenidate response in children with ADHD
Trinity College Dublin
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Grant Holder Project Title Award
Dr Catherine Godson An investigation of the potential antifibrotic €160,760
Department of Medicine and actions of lipoxins in renal cells
Therapeutics 
University College Dublin
Professor Ian Graham The role of endogenous arginine derivatives in €118,586
Department of Cardiology atherosclerotic vascular disease
AMNCH
Dr Ziarih Hawi Linkage disequilibrium mapping and mutation €119,500
Department of Genetics analysis of serotonergic candidate genes in 
Trinity College Dublin Attention Deficit Hyperactivity Disorder (ADHD)
Dr Desmond Higgins Computer-aided cancer identification from gene €167,820
Department of Biochemistry expression profile data
University College Cork
Dr Alan K Keenan Adaptation of environment-sensitive hydrogels to €170,806
Department of Pharmacology local delivery of potential anti-retinosis therapy
University College Dublin
Dr Alan Kelly Access for all: a formal methodology for €71,224
Department of Community quantifying and planning access to health
Health and General Practice services in Ireland
AMNCH
Dr B Therese Kinsella Investigation of the role of the calcium €157,806
Department of Biochemistry (Ca)-dependent and the Ca-independent/Rho 
University College Dublin A pathways in thromboxance receptor (TP) 
signalling within the vasculature
Professor Brian Lawlor The role of haemochromatosis mutations in €54,086
Mercer’s Institute for Research Alzheimer’s disease
on Ageing 
St James’s Hospital
Dr Aideen Long Transcriptional regulation of protein Kinase C €158,934
Department of Biochemistry isoforms in response to T cell activation
Royal College of Surgeons in 
Ireland
Professor Noel F Lowndes Biochemistry of the Brca1 tumour suppressor €153,728
Department of Biochemistry
NUI Galway
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Grant Holder Project Title Award
Dr John P Lowry The role of astrocytes in brain energy metabolism €121,046
Department of Chemistry
NUI Maynooth
Dr Padraic Mac Mathuna Development of a model colorectal cancer €146,311
Gastrointestinal Unit screening clinic
Mater Misericordiae Hospital
Dr John James Mackrill Relationships between hypoxia and Ca signalling €105,500
Department of Biochemistry in a human neuroblastoma cell line
University College Cork
Professor Finian Martin Functional and morphological maintenance of €153,000
Department of Pharmacology mammary epithelial structures by the combined 
University College Dublin action of extracellular matrix components and 
glucocorticoids: studies on a novel cell culture 
model system
Dr Kieran McDermott Astroglial diversity and selective dopaminergic €103,200
Department of Anatomy neuronal degeneration: implications for 
University College Cork Parkinson’s disease
Professor TJ McKenna Structure and etiology of macroprolactin €109,900
Department of Endocrinology
St Vincent’s University Hospital
Professor P McLoughlin Angiogenesis in the pulmonary circulation: €124,200
Department of Physiology pathogenetic role in chronic lung infection
University College Dublin
Dr Hilary McMahon The prion protein’s role in the cellular oxidative €138,366
Department of Industrial state
Microbiology
University College Dublin
Dr Anthony Moran Characterisation of the capsular and €150,654
Department of Microbiology exopolysaccharides of Campylobacter jejuni 
NUI Galway and Campylobacter coli and studies on their 
biological relevance
Professor John Morrison The Rho/Rho-kinase system and regulation of €103,315
Clinical Science Institute maternal, placental and fetal vascular smooth 
NUI Galway muscle in normal pregnancy, pre-eclampsia 
and fetal growth restriction
Grant Holder Project Title Award
Dr Paul Moynagh Exploring the role of PRISM in inflammatory €151,000
Department of Pharmacology signalling pathways
University College Dublin
Dr Philip Newsholme Nutrient, hormone and sulphonylurea regulation €149,000
Department of Biochemistry of metabolic/secretory pathway activity and gene 
University College Dublin expression in pancreatic bata cells: use of 
expression profiling and NMR to probe bata cell 
function
Dr Catherine M Nolan Is translation of the IGF-I receptor coding €107,400
Department of Zoology sequence negatively regulated by an upstream 
University College Dublin open reading frame?
Professor Timothy O’Brien A gene therapy approach to atherosclerosis by €149,468
University College Hospital paraoxonase gene transfer
Galway
Dr Joe O’Connell Role of Fas ligand (FasL/CD95L) in metastatic €155,652
Department of Medicine colonisation of the liver by colon cancer cells
Cork University Hospital
Professor Brian O’Connell Antifungal mechanism of human salivary histatin- €162,099
Department of Restorative identification and characterisation of molecular
Dentistry targets
Trinity College Dublin 
Dr Rosemary O’Connor Role of RACK-1 and Serine phosphorylation in €155,837
Department of Biochemistry IR/IGF-1R function
University College Cork
Dr Kay Ohlendieck Proteomics analysis of adult skeletal muscle fibre €150,000
Department of Pharmacology transformation: a neurobiological model system  
University College Dublin of electro-stimulation therapy
Professor Denis O’Mullane A study of the relationship among oral hygiene €155,085
Oral Health Services habits, salivary fluoride levels and dental caries
Research Centre
Cork University Hospital
Professor Luke O’Neill Signal transduction pathways activated by the €158,535
Department of Biochemistry novel adapter protein Mal (MyD88 adapter-like), 
Trinity College a critical participant in Toll-like receptor-4 action
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Grant Holder Project Title Award
Dr Cora O’Neill Characterisation of beta-site amyloid precursor €100,490
Department of Biochemistry protein cleaving enzyme (BACE) in Alzheimer’s 
University College Cork disease brain
Dr Finbarr O’Sullivan Statistical methods for quantitiative imaging with €157,429
Department of Statistics positron emission tomography
University College Cork
Dr Dmitri B Papkovsky Respirometric biochip and system for embryo €154,700
Department of Biochemistry assessment
University College Cork
Professor Ivan Perry The Diabetes QoL Study: determinants of quality €124,444
Department of Epidemiology of life in Irish patients with diabetes
and Public Health 
University College Cork
Professor Denis J Reen Regulation of monocyte responses by apoptotic €134,562
Children’s Research Centre cells
Our Lady’s Hospital for
Sick Children
Dr Aideen Sullivan Establishment of neurotrophin-expressing €131,900
Department of Anatomy dopaminergic cells for transplantation in 
University College Cork Parkinson’s disease
Dr Clifford Taggart Inhibition of the ubiquitin-proteasome pathway €60,000
Department of Medicine by secretory leucoprotease inhibitor
Beaumont Hospital
Dr Olga N Tucker The role of the arachidonic acid metabolic  €115,310
Department of Surgery pathway in pancreatic cancer
Cork University Hospital
Dr Dermot Walls bfl-1/A1, a target for the Epstein-Barr virus LMP1, €156,635
School of Biotechnology EBNA2 and related cell signalling pathway
Dublin City University
Dr Helen Whelton Economic modelling of services utilisation data €155,000
Oral Health Services and epidemiological data for oral health services
Research Centre
University Dental School
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Research Project Grants – Inter-Disciplinary
Grant Holder Project Title Award
Dr Clare Meaney Synthesis, formulation and evaluation of novel €128,315
School of Pharmacy treatments for accelerating wound repair
Royal College of Surgeons 
in Ireland
Professor Keith Tipton Exploiting chemical libraries, structural analysis €130,000
Department of Biochemistry and biological testing to design thyrotropin-
Trinity College Dublin releasing hormone-degrading ectoenzyme 
(TRH-DE) inhibitors for use in the treatment of 
CNS disorders
Research Project Grants – Ireland–Northern Ireland Co-operation
Grant Holder Project Title Award
Professor Oliver Fitzgerald The consistency of eligibility and monitoring €15,655
Department of Rheumatology decisions among rheumatologists using anti-TNF 
St Vincent’s University Hospital alpha therapy in adults with rheumatoid arthritis
Dr Orla Hardiman An all-Ireland study of the epidemiology, clinical €150,500
Department of Neurology features and services for people with motor 
Beaumont Hospital neuron disease
Professor Timothy O’Brien Targeting of inducible nitric oxide synthase  €163,222
Department of Medicine (iNOS) gene therapy to tumours by systemic 
NUI Galway delivery using modified adenoviral vectors
Professor Colm O’Brien Molecular mechanisms of retinal pericyte €129,729
Institute of Ophthalmology apoptosis in diabetic retinopathy
UCD/Mater Misericordiae 
Hospital
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Appendix II
Research and Development for Health Awards 2002
Cochrane Fellowships (co-funded with the R&D Office, Belfast)
Name Institution Title of Review  
Dr Paul Beirne University Dental School and Hospital Frequency of examination and 
Cork scaling and polishing for 
maintaining oral health in adults  
Dr Jim Jamison Research Affiliate Antibiotic management of urinary 
Queen’s University of Belfast  tract problems in people with 
spinal injury
Dr Alan Moss Gastroenterology Unit Palliative stents for pancreatic
Mater Misericordiae Hospital Dublin cancer  
Dr Emma McCall School of Medicine Plastic barriers for the reduction
Queen’s University of Belfast of heat loss in pre-term infants 
immediately after birth  
Dr Judy Bradley School of Rehabilitation Effectiveness of short-term 
Sciences ambulatory oxygen for obstructive
University of Ulster pulmonary disease  
at Jordanstown
Cancer Consortium Clinical Trials Training for Nurses 
Name Discipline Institution
Ms Marie Cox Clinical Nurse Specialist (Oncology) University College Hospital Galway
Ms Louise Sherwin Staff Nurse St Luke’s Hospital Dublin
Cancer Consortium Summer Curriculum in Cancer Prevention 
Name Institution Course Attended  
Discipline
Piaras O’ Lorcain Department of Public Health Eastern Principles and practices of cancer
Surveillance Scientist Regional Health Authority  prevention and control
Sinead O’Toole School of Nursing and Midwifery Principles and practices of cancer
College Lecturer  University College Dublin prevention and control
Eileen Nolan HOPE Directorate Principles and practices of cancer
Cancer Register St James’s Hospital prevention and control
Project Officer 
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Name Institution Course Attended  
Discipline
Irene Graham School of Nursing and Midwifery Principles and practices of cancer
Nurse Tutor Sligo General Hospital prevention and control
Sandra Deady National Cancer Registry Principles and practices of cancer
Data Analyst prevention and control
Zoë Kelly Department of Pharmacology Molecular prevention
PhD Student University College Dublin 
John V Reynolds Department of Clinical Surgery Molecular prevention
Professor of Surgery St James’s Hospital
Head of Department
Helen Barrett Beaumont Hospital Molecular prevention
Pathology Registrar
Helen Lambkin School of Biological Sciences  Molecular prevention
Lecturer Dublin Institute of Technology
Mark Lawlor Cancer Strategy Group Molecular prevention
Chief Molecular St James’s Hospital
Geneticist
Michael Cairns National Diagnostics Centre Molecular prevention
Group Leader National University of Ireland
Molecular Biology Galway
Group
Mirellie Crampe Cancer Molecular Diagnosis Principles and practices of cancer
Clinical Scientist St James’s Hospital prevention and control; 
Molecular prevention 
Eilis Foran Biochemistry Principles and practices of cancer
PhD Student Royal College of Surgeons in Ireland prevention and control; 
Molecular prevention 
Sajid Durrani Medical Oncology Principles and practices of cancer
Registrar University College Galway prevention and control; 
Molecular prevention 
Colm O’Morain Department of Gastroenterology Principles and practices of cancer
Consultant Physician  Adelaide/ Meath Hospitals prevention and control;
/ Gastroenterologist     Molecular prevention 
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Cancer Consortium Clinical Trials Hospital Network 
Infrastructure awards to hospitals to build capacity to conduct cancer clinical trials 
Hospital Principal Investigators
St Luke’s Hospital and Dr John Armstrong and Dr John Crown
St Vincent’s University Hospital Dublin 
Cork University Hospital Dr Oscar Breathnach and Dr Seamus O’ Reilly  
Beaumont Hospital Dublin Dr Liam Grogan
University College Hospital Galway Dr Macon Keane and Professor Ernest Egan
Mid Western Regional Hospital Limerick Dr Maeve Leahy and Dr Seamus O’Reilly  
Mater Misericordiae Hospital Dublin Dr John McCaffrey and Dr Desmond Kearney
St James’s Hospital Dublin Dr John Kennedy and Professor John Reynolds
Tallaght (AMNCH) Hospital Dublin Dr Diarmuid O’ Riordain and Dr Eileen O’Reilly  
Waterford Regional Hospital Dr Paula Calvert and Dr Brian Cantwell
Cancer Consortium All Ireland Cooperative Group (AICG) Award
A two-year planning grant of €1 million was awarded to ICORG and CRSC to co-ordinate the
headquarters and statistical and data management functions of the hospital network.
Irish Clinical Oncology Research Group Clinical Research Support Centre
(ICORG) (CRSC)
Dr John Armstrong, Chairman Dr Karen Bailie, Director
120 Pembroke Road Clinical Research Support Centre
Dublin Royal Group of Hospitals
Belfast
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Notes
Notes
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